Is Amgen's Dividend Safe?
(NASDAQ: AMGN) is a global leader in biotechnology, with a market capitalization of over $121 billion. The company has a proven track record of developing breakthrough therapies for challenging diseases and has been rewarding its shareholders with dividends since 2011.
Amgen's dividend has grown by a remarkable 353% over the past 10 years, reaching $2.13 per share in the first quarter of 2023. The company's annualized dividend yield is currently 3.8%, which is among the highest within the large-cap biotech space. As a result, Amgen has become a top dividend stock for many individual and institutional investors.
Image source: Getty Images.
Source Fool.com
Amgen Inc. Aktie
333,60 €
1,35 %
Amgen Inc. ist ein klarer Community-Favorit mit mehr Buy- als Sell-Einschätzungen.
Für Amgen Inc. ergibt sich ein negatives Potenzial von -1.08%, obwohl das Kursziel von 330 € unter dem aktuellen Kurs von 333.6 € liegt.
